Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-05-13

FDA Approved: TRIHEXYPHENIDYL HYDROCHLORIDE — Supplemental Application (Akorn)

View source ↗

Summary

FDA approved a supplemental application for Akorn's Trihexyphenidyl hydrochloride.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trihexyphenidyl hydrochloride (Trihexyphenidyl hydrochloride)

Snippet

SUPPL AP for TRIHEXYPHENIDYL HYDROCHLORIDE (TRIHEXYPHENIDYL HYDROCHLORIDE)